143 related articles for article (PubMed ID: 35850360)
21. Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression.
Masugi Y; Takamatsu M; Tanaka M; Hara K; Inoue Y; Hamada T; Suzuki T; Arita J; Hirose Y; Kawaguchi Y; Nakai Y; Oba A; Sasahira N; Shimane G; Takeda T; Tateishi K; Uemura S; Fujishiro M; Hasegawa K; Kitago M; Takahashi Y; Ushiku T; Takeuchi K; Sakamoto M;
J Pathol Clin Res; 2023 Sep; 9(5):339-353. PubMed ID: 37291757
[TBL] [Abstract][Full Text] [Related]
22. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
[TBL] [Abstract][Full Text] [Related]
23. Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma.
Koh Y; Kim H; Joo SY; Song S; Choi YH; Kim HR; Moon B; Byun J; Hong J; Shin DY; Park S; Lee KH; Lee KT; Lee JK; Park D; Lee SH; Jang JY; Lee H; Kim JA; Yoon SS; Park JK
J Transl Med; 2023 Oct; 21(1):730. PubMed ID: 37848935
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic Cancer Research beyond DNA Mutations.
Sato H; Sasaki K; Hara T; Tsuji Y; Arao Y; Otsuka C; Hamano Y; Ogita M; Kobayashi S; di Luccio E; Hirotsu T; Doki Y; Eguchi H; Satoh T; Uchida S; Ishii H
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291712
[TBL] [Abstract][Full Text] [Related]
25. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.
Bazzichetto C; Luchini C; Conciatori F; Vaccaro V; Di Cello I; Mattiolo P; Falcone I; Ferretti G; Scarpa A; Cognetti F; Milella M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266496
[TBL] [Abstract][Full Text] [Related]
26. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
[TBL] [Abstract][Full Text] [Related]
27. Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan.
Sakakida T; Ishikawa T; Doi T; Morita R; Kataoka S; Miyake H; Yamaguchi K; Moriguchi M; Sogame Y; Yasuda H; Iwasaku M; Konishi H; Takayama K; Itoh Y
J Gastroenterol; 2023 Jun; 58(6):575-585. PubMed ID: 37029223
[TBL] [Abstract][Full Text] [Related]
28.
Pan M; Jiang C; Zhang Z; Achacoso N; Alexeeff S; Solorzano AV; Tse P; Chung E; Sundaresan T; Suga JM; Thomas S; Habel LA
JCO Precis Oncol; 2023 May; 7():e2200570. PubMed ID: 37163715
[TBL] [Abstract][Full Text] [Related]
29. Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers:
Ciulla C; Luchini C
Expert Rev Mol Diagn; 2024 May; 24(5):355-362. PubMed ID: 38708441
[TBL] [Abstract][Full Text] [Related]
30. Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma.
Hayashi A; Yavas A; McIntyre CA; Ho YJ; Erakky A; Wong W; Varghese AM; Melchor JP; Overholtzer M; O'Reilly EM; Klimstra DS; Basturk O; Iacobuzio-Donahue CA
Mod Pathol; 2020 Sep; 33(9):1822-1831. PubMed ID: 32350415
[TBL] [Abstract][Full Text] [Related]
31. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
[TBL] [Abstract][Full Text] [Related]
32. Molecular Pathogenesis of Pancreatic Cancer.
Grant TJ; Hua K; Singh A
Prog Mol Biol Transl Sci; 2016; 144():241-275. PubMed ID: 27865459
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic and Molecular Features of Pancreatic Ductal Adenocarcinomas Harboring Alterations in COMPASS-like Complex Genes.
Hissong E; Zhao L; Shi J
Arch Pathol Lab Med; 2023 Sep; 147(9):1050-1059. PubMed ID: 36508685
[TBL] [Abstract][Full Text] [Related]
34. Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma.
Topham JT; Tsang ES; Karasinska JM; Metcalfe A; Ali H; Kalloger SE; Csizmok V; Williamson LM; Titmuss E; Nielsen K; Negri GL; Spencer Miko SE; Jang GH; Denroche RE; Wong HL; O'Kane GM; Moore RA; Mungall AJ; Loree JM; Notta F; Wilson JM; Bathe OF; Tang PA; Goodwin R; Morin GB; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Schaeffer DF; Renouf DJ
Nat Commun; 2022 Oct; 13(1):5941. PubMed ID: 36209277
[TBL] [Abstract][Full Text] [Related]
35. The molecular landscape of pancreatic ductal adenocarcinoma.
Sivapalan L; Kocher HM; Ross-Adams H; Chelala C
Pancreatology; 2022 Nov; 22(7):925-936. PubMed ID: 35927150
[TBL] [Abstract][Full Text] [Related]
36. Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma.
Sekiya S; Fukuda J; Yamamura R; Ooshio T; Satoh Y; Kosuge S; Sato R; Hatanaka KC; Hatanaka Y; Mitsuhashi T; Nakamura T; Matsuno Y; Hirano S; Sonoshita M
Cancer Res; 2023 Aug; 83(16):2704-2715. PubMed ID: 37378549
[TBL] [Abstract][Full Text] [Related]
37. Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice.
Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
[TBL] [Abstract][Full Text] [Related]
38. Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.
Reissig TM; Tzianopoulos I; Liffers ST; Rosery VK; Guyot M; Ting S; Wiesweg M; Kasper S; Meister P; Herold T; Schmidt HH; Schumacher B; Albers D; Markus P; Treckmann J; Schuler M; Schildhaus HU; Siveke JT
ESMO Open; 2023 Jun; 8(3):101539. PubMed ID: 37148593
[TBL] [Abstract][Full Text] [Related]
39. A novel method for detection of pancreatic Ductal Adenocarcinoma using explainable machine learning.
Aslam M; Rajbdad F; Azmat S; Li Z; Boudreaux JP; Thiagarajan R; Yao S; Xu J
Comput Methods Programs Biomed; 2024 Mar; 245():108019. PubMed ID: 38237450
[TBL] [Abstract][Full Text] [Related]
40. Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction.
Ziogas DC; Papadopoulou E; Gogas H; Sakellariou S; Felekouras E; Theocharopoulos C; Stefanou DT; Theochari M; Boukovinas I; Matthaios D; Koumarianou A; Zairi E; Liontos M; Koutsoukos K; Metaxa-Mariatou V; Kapetsis G; Meintani A; Tsaousis GN; Nasioulas G
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
